QQQ   292.96 (+0.93%)
AAPL   143.54 (+0.38%)
MSFT   245.97 (+1.34%)
META   147.99 (+0.63%)
GOOGL   97.70 (+0.78%)
AMZN   103.01 (+2.45%)
TSLA   172.95 (+3.77%)
NVDA   195.14 (+1.84%)
NIO   12.21 (+1.58%)
BABA   110.94 (-0.23%)
AMD   74.30 (+2.55%)
T   20.20 (+0.20%)
MU   60.01 (-2.75%)
F   13.33 (+3.41%)
CGC   2.93 (+3.17%)
GE   80.57 (-0.32%)
DIS   108.21 (+0.58%)
AMC   5.13 (+2.40%)
PFE   43.56 (+0.02%)
PYPL   80.85 (+1.52%)
NFLX   353.95 (+0.24%)
QQQ   292.96 (+0.93%)
AAPL   143.54 (+0.38%)
MSFT   245.97 (+1.34%)
META   147.99 (+0.63%)
GOOGL   97.70 (+0.78%)
AMZN   103.01 (+2.45%)
TSLA   172.95 (+3.77%)
NVDA   195.14 (+1.84%)
NIO   12.21 (+1.58%)
BABA   110.94 (-0.23%)
AMD   74.30 (+2.55%)
T   20.20 (+0.20%)
MU   60.01 (-2.75%)
F   13.33 (+3.41%)
CGC   2.93 (+3.17%)
GE   80.57 (-0.32%)
DIS   108.21 (+0.58%)
AMC   5.13 (+2.40%)
PFE   43.56 (+0.02%)
PYPL   80.85 (+1.52%)
NFLX   353.95 (+0.24%)
QQQ   292.96 (+0.93%)
AAPL   143.54 (+0.38%)
MSFT   245.97 (+1.34%)
META   147.99 (+0.63%)
GOOGL   97.70 (+0.78%)
AMZN   103.01 (+2.45%)
TSLA   172.95 (+3.77%)
NVDA   195.14 (+1.84%)
NIO   12.21 (+1.58%)
BABA   110.94 (-0.23%)
AMD   74.30 (+2.55%)
T   20.20 (+0.20%)
MU   60.01 (-2.75%)
F   13.33 (+3.41%)
CGC   2.93 (+3.17%)
GE   80.57 (-0.32%)
DIS   108.21 (+0.58%)
AMC   5.13 (+2.40%)
PFE   43.56 (+0.02%)
PYPL   80.85 (+1.52%)
NFLX   353.95 (+0.24%)
QQQ   292.96 (+0.93%)
AAPL   143.54 (+0.38%)
MSFT   245.97 (+1.34%)
META   147.99 (+0.63%)
GOOGL   97.70 (+0.78%)
AMZN   103.01 (+2.45%)
TSLA   172.95 (+3.77%)
NVDA   195.14 (+1.84%)
NIO   12.21 (+1.58%)
BABA   110.94 (-0.23%)
AMD   74.30 (+2.55%)
T   20.20 (+0.20%)
MU   60.01 (-2.75%)
F   13.33 (+3.41%)
CGC   2.93 (+3.17%)
GE   80.57 (-0.32%)
DIS   108.21 (+0.58%)
AMC   5.13 (+2.40%)
PFE   43.56 (+0.02%)
PYPL   80.85 (+1.52%)
NFLX   353.95 (+0.24%)
NASDAQ:PETS

PetMed Express - PETS Stock Forecast, Price & News

$21.85
+0.52 (+2.44%)
(As of 01/31/2023 11:39 AM ET)
Add
Compare
Today's Range
$21.18
$21.88
50-Day Range
$17.16
$21.52
52-Week Range
$17.08
$29.53
Volume
74,125 shs
Average Volume
338,546 shs
Market Capitalization
$460.60 million
P/E Ratio
28.01
Dividend Yield
5.58%
Price Target
$18.00

PetMed Express MarketRank™ Forecast

Analyst Rating
Reduce
1.00 Rating Score
Upside/​Downside
15.6% Downside
$18.00 Price Target
Short Interest
Bearish
19.92% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.90mentions of PetMed Express in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
16.00%
From $0.75 to $0.87 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.65 out of 5 stars

Retail/Wholesale Sector

182nd out of 216 stocks

Drug Stores & Proprietary Stores Industry

4th out of 5 stocks


PETS stock logo

About PetMed Express (NASDAQ:PETS) Stock

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Stock News Headlines

GRAPHITE: "Essential for America's National Defense"
Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider.
PETS PetMed Express, Inc.
PetMed Express buys PetCareRX for $36M
Without Graphite, There Would Be ZERO EV Batteries!
Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.
PetMed Agrees To Acquire PetCareRx
PetMeds® to Acquire PetCareRx
Best Cheap Pet Insurance Of 2022
See More Headlines
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Company Calendar

Last Earnings
11/07/2022
Ex-Dividend for 11/30 Dividend
11/17/2022
Dividend Payable
11/30/2022
Today
1/31/2023
Next Earnings (Confirmed)
2/06/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
219
Year Founded
1996

Price Target and Rating

Average Stock Price Forecast
$18.00
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$18.00
Forecasted Upside/Downside
-17.6%
Consensus Rating
Reduce
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

Net Income
$21.10 million
Pretax Margin
7.76%

Debt

Sales & Book Value

Annual Sales
$273.42 million
Cash Flow
$1.19 per share
Book Value
$6.78 per share

Miscellaneous

Free Float
20,212,000
Market Cap
$460.60 million
Optionable
Optionable
Beta
0.59

Social Links


Key Executives

  • Matthew N. Hulett
    President, Chief Executive Officer & Director
  • Christine Chambers
    Chief Financial Officer
  • Mark Moseley
    Chief Technology & Information Officer
  • Carolyn Carden
    Vice President-Product Management
  • Eddie Khoriaty
    Dir-Pharmacy Services & Prescription Dept. Manager













PETS Stock - Frequently Asked Questions

Should I buy or sell PetMed Express stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" PETS shares.
View PETS analyst ratings
or view top-rated stocks.

What is PetMed Express' stock price forecast for 2023?

1 analysts have issued twelve-month price objectives for PetMed Express' shares. Their PETS share price forecasts range from $18.00 to $18.00. On average, they expect the company's share price to reach $18.00 in the next year. This suggests that the stock has a possible downside of 15.6%.
View analysts price targets for PETS
or view top-rated stocks among Wall Street analysts.

How have PETS shares performed in 2023?

PetMed Express' stock was trading at $17.70 on January 1st, 2023. Since then, PETS shares have increased by 20.5% and is now trading at $21.33.
View the best growth stocks for 2023 here
.

When is PetMed Express' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023.
View our PETS earnings forecast
.

How can I listen to PetMed Express' earnings call?

PetMed Express will be holding an earnings conference call on Monday, February 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13735907".

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) posted its earnings results on Monday, November, 7th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.27 by $0.14. The business had revenue of $65.39 million for the quarter, compared to analysts' expectations of $65 million. PetMed Express had a trailing twelve-month return on equity of 11.17% and a net margin of 5.98%.

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express declared a quarterly dividend on Monday, November 7th. Investors of record on Friday, November 18th will be paid a dividend of $0.30 per share on Wednesday, November 30th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.63%. The ex-dividend date is Thursday, November 17th.
Read our dividend analysis for PETS
.

Is PetMed Express a good dividend stock?

PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 5.58%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 153.85%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 137.93% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for PETS.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by a variety of institutional and retail investors. Top institutional investors include North Star Investment Management Corp. (0.25%), Inlet Private Wealth LLC (0.19%), Exchange Traded Concepts LLC (0.10%), Exchange Traded Concepts LLC (0.10%), James Investment Research Inc. (0.08%) and Yousif Capital Management LLC (0.06%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends
.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetMed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $21.33.

How much money does PetMed Express make?

PetMed Express (NASDAQ:PETS) has a market capitalization of $449.64 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $0.78 on an earnings per share basis.

How many employees does PetMed Express have?

The company employs 219 workers across the globe.

How can I contact PetMed Express?

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445.

This page (NASDAQ:PETS) was last updated on 1/31/2023 by MarketBeat.com Staff